PRCM
SCR

Pine River Capital Management’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Pine River Capital Management’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-430,444
Closed -$4.07M – 750
2013
Q3 		$4.07M Buy
430,444
+176,145
+69% +$1.67M 0.04% 288
2013
Q2 		$2.41M Buy
+254,299
New +$2.35M 0.04% 309

Other funds holding SCR

SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LOM
Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Pine River Capital Management's SCR Position: Q4 2013 in Review

Pine River Capital Management sold out of SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) in Q4 2013, closing a stake of 430,444 shares — an estimated $4.07M sold.

Pine River Capital Management first reported a position in SCR in Q2 2013 and held it in 2 quarters. The position peaked at $4.07M in Q3 2013. 12 funds tracked by Wall St. Rank hold SCR as of Q4 2013.

  • Pine River Capital Management reported no remaining SIMCERE PHARMACEUTICAL GROUP, ADS position as of Q4 2013 after selling out during the quarter.
  • Pine River Capital Management sold 430,444 SIMCERE PHARMACEUTICAL GROUP, ADS shares in Q4 2013, an estimated $4.07M.
  • Pine River Capital Management first reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS in Q2 2013 and held it in 2 quarters.
  • Pine River Capital Management's SIMCERE PHARMACEUTICAL GROUP, ADS position peaked at $4.07M in Q3 2013.
  • 12 funds tracked by Wall St. Rank held SIMCERE PHARMACEUTICAL GROUP, ADS as of Q4 2013.

Based on Pine River Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.